PRESS RELEASE published on 11/23/2024 at 10:54, 1 year 4 months ago Inside Information / Other news releases TME Pharma presents poster on NOX-A12 inhibition of CXCL12 in glioblastoma at 2024 SNO Annual Meeting, demonstrating enhanced anti-tumor immune responses in brain cancer models Glioblastoma TME Pharma NOX-A12 CXCL12 Inhibition SNO Annual Meeting
BRIEF published on 08/12/2024 at 19:05, 1 year 7 months ago TME Pharma Increases Allocated Resources for Liquidity Contract Liquidity Contract INVEST SECURITIES AMF Decision TME Pharma Share Allocation
PRESS RELEASE published on 08/12/2024 at 19:00, 1 year 7 months ago Acquisition or disposal of the issuer's own shares / Information relating to the liquidity contract TME Pharma increases resources for liquidity contract with Invest Securities to support cash balance and securities. Details of the update provided in accordance with AMF regulations Liquidity Contract Biotechnology INVEST SECURITIES AMF Regulations TME Pharma
Published on 04/09/2026 at 16:00, 2 hours 54 minutes ago Banff Half Marathon Completes 2025 Emissions Assessment, Supporting Climate Action with Karbon-X
Published on 04/09/2026 at 14:40, 4 hours 14 minutes ago Silver X Delivers Production Growth During the First Quarter of 2026
Published on 04/09/2026 at 14:00, 4 hours 54 minutes ago Orogen Royalties Announces Mineral Reserve and Resource Update on Producing Ermitaño Royalty
Published on 04/09/2026 at 13:30, 5 hours 24 minutes ago Datametrex Receives $6M Purchase Order for Data Centre from Fortune 500 Conglomerate
Published on 04/09/2026 at 13:30, 5 hours 24 minutes ago ESGold Advances Toward Production and Exploration Drilling as Mill Buildout Progresses in Parallel
Published on 04/09/2026 at 18:15, 38 minutes ago REPLY: Launch of a share buyback program for a maximum number of 3,607,950 shares
Published on 04/09/2026 at 15:40, 3 hours 14 minutes ago Form 8.3 - The Vanguard Group, Inc.: LondonMetric Property plc
Published on 04/09/2026 at 15:39, 3 hours 14 minutes ago Form 8.3 - The Vanguard Group, Inc.: Schroders plc
Published on 04/09/2026 at 18:35, 19 minutes ago Availability of proxy documents for the Combined General Meeting of April 30, 2026
Published on 04/09/2026 at 15:57, 2 hours 56 minutes ago Filing of CNP Assurances SA 2025 universal registration document and 2025 Solvency and Financial Condition Reports
Published on 04/09/2026 at 07:00, 11 hours 54 minutes ago bioMérieux Unveils its BIOFIRE® SPOTFIRE® Molecular Testing Solution for the Pharmaceutical Industry, Redefining Rapid Mycoplasma Testing
